1. Risk-Based Monitoring: Implications of the US FDA Guidance for Pharmaceutical Physicians

   • Randall R. Stoltz

   Current Opinion 22 October 2013 Pages: 279 - 281

2. Recent Changes to Clinical Trial Regulation in India: Focus on Serious Adverse Events, Compensation and Registration of Ethics Committees

   • Manoj Karwa
   • Saurabh Arora
   • Shilpa Garg Agrawal

   Current Opinion 15 October 2013 Pages: 283 - 288

3. The Development of Pharmaceutical Medicine in Hungary

   • Sandor Kerpel-Fronius

   Review Article 15 October 2013 Pages: 289 - 295

   

4. Drugs in Clinical Development for Asthma: Summary and Table

   Adis Profile Summary 10 October 2013 Pages: 297 - 312

5. Forum

   Update 09 October 2013 Pages: 313 - 319

6. Journal Watch

   Update 05 October 2013 Pages: 321 - 334

7. Major Pharmaceutical Conferences and Courses

   Update 09 October 2013 Pages: 335 - 337